AGTR2 and glioblastoma: Here, we investigated the gene expression of RAS components (ATP6AP2, AGTR1, AGTR2, ACE, AGT, and REN) in glioblastoma patient samples from The Cancer Genome Atlas (TCGA) and their association with survival outcomes and the expression of TME pathways.